Sale!

PSEN1 Gene Pick Disease Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PSEN1 Gene Pick Disease Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the PSEN1 gene, which are associated with Pick’s disease, a type of frontotemporal dementia. This condition is characterized by changes in personality, behavior, and language due to brain cell damage. The PSEN1 gene plays a crucial role in the production of the presenilin 1 protein, involved in the processing of amyloid precursor protein, a substance that, when improperly cleaved, can lead to the accumulation of amyloid plaques, a hallmark of several forms of dementia, including Pick’s disease.

The test is conducted through a blood sample, where DNA is extracted and analyzed for specific mutations in the PSEN1 gene. This genetic testing is crucial for individuals with a family history of Pick’s disease or early-onset dementia, as it can provide vital information for the management and understanding of the condition. The cost of the PSEN1 Gene Pick Disease Genetic Test at DNA Labs UAE is 4400 AED, reflecting the sophisticated technology and expertise required to perform this detailed genetic analysis. Early detection through this test can be instrumental in planning the appropriate care and support for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PSEN1 Gene Pick Disease Genetic Test

Test Name: PSEN1 Gene Pick Disease Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PSEN1 Gene Pick Disease NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PSEN1 Gene Pick Disease.

Test Details

The PSEN1 gene is associated with Pick disease, which is a rare neurodegenerative disorder characterized by progressive cognitive decline, behavioral changes, and language impairment. Next-generation sequencing (NGS) genetic testing can be used to analyze the PSEN1 gene for any mutations or variations that may be responsible for the development of Pick disease.

NGS technology allows for the simultaneous sequencing of multiple genes, including the PSEN1 gene, in a more efficient and cost-effective manner compared to traditional sequencing methods. By analyzing the entire coding region of the PSEN1 gene, NGS testing can identify any pathogenic mutations or variations that may be present.

The NGS genetic test for PSEN1 gene mutations can be used for diagnostic purposes in individuals suspected to have Pick disease based on their clinical symptoms and family history. It can also be used for carrier testing in individuals with a family history of Pick disease who may be at risk of passing on the genetic mutation to their children.

Identifying PSEN1 gene mutations through NGS testing can help in confirming the diagnosis of Pick disease, providing information about disease progression and prognosis, and guiding treatment decisions. It can also be useful for genetic counseling and family planning purposes.

It is important to note that genetic testing should be conducted and interpreted by qualified healthcare professionals with expertise in genetic counseling and neurogenetics. The results of genetic testing should be interpreted in conjunction with clinical findings and family history to provide an accurate diagnosis and appropriate management plan for individuals suspected to have Pick disease.

Test Name PSEN1 Gene Pick disease Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PSEN1 Gene Pick disease NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PSEN1 Gene Pick disease
Test Details

PSEN1 gene is associated with Pick disease, which is a rare neurodegenerative disorder characterized by progressive cognitive decline, behavioral changes, and language impairment. Next-generation sequencing (NGS) genetic testing can be used to analyze the PSEN1 gene for any mutations or variations that may be responsible for the development of Pick disease.

NGS technology allows for the simultaneous sequencing of multiple genes, including the PSEN1 gene, in a more efficient and cost-effective manner compared to traditional sequencing methods. By analyzing the entire coding region of the PSEN1 gene, NGS testing can identify any pathogenic mutations or variations that may be present.

The NGS genetic test for PSEN1 gene mutations can be used for diagnostic purposes in individuals suspected to have Pick disease based on their clinical symptoms and family history. It can also be used for carrier testing in individuals with a family history of Pick disease who may be at risk of passing on the genetic mutation to their children.

Identifying PSEN1 gene mutations through NGS testing can help in confirming the diagnosis of Pick disease, providing information about disease progression and prognosis, and guiding treatment decisions. It can also be useful for genetic counseling and family planning purposes.

It is important to note that genetic testing should be conducted and interpreted by qualified healthcare professionals with expertise in genetic counseling and neurogenetics. The results of genetic testing should be interpreted in conjunction with clinical findings and family history to provide an accurate diagnosis and appropriate management plan for individuals suspected to have Pick disease.